WuXi Biologics Achieved Record Growth and Profitability in 2021 Banner Year for Commercial Manufacturing
WuXi Biologics is pleased to announce its audited annual results for the year ended December 31, 2021. Our CRDMO business model and a focus on innovation, quality, expertise, project execution and delivery timelines, along with our “Follow and Win the Molecule” strategies helped us capture opportunities, increase our market share, and achieve new revenue and profitability records in 2021.
WuXi Vaccines and BravoBio Sign Letter of Intent for Long-Term Collaboration – Accelerating Development and Commercial Manufacturing of Innovative Vaccines
WuXi Biologics Completes GMP Inspection by South Korea’s Ministry of Food and Drug Safety for Drug Substance Facility Read More
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year Read More
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
The Watershed Moment for ADCs has Arrived - More efficient CMC development is the last barrier
Ten years ago, antibody-drug conjugates (ADCs) were being talked about as the next big breakthrough in pharmaceuticals due to their highly targeted approach, especially in areas such as oncology... Download
7 Key Questions for Understanding the Benefits of Scale-out Biomanufacturing
Through a Question-and-Answer (Q&A) format, we review the inherent benefits of this bioproduction strategy as you scale throughout clinical trials and the significant cost advantages once in commercial production. Download
WuXi Biologics is committed to creating a workplace free of bias, stereotypes, and discrimination; a world that is diverse, equitable, and inclusive; a world where difference is valued and celebrated. We strive to create equal working opportunities, so that all employees believe their contributions are essential to the company’s success. For instance, over 50% of the company’s global workforce is female as is nearly 50% of the leadership team.
We celebrated International Women’s Day in March with our Women in STEM Employee Stories (see below). #BreakTheBias
WuXi Biologics Furthers DE&I Commitment with Dedicated Advocacy for International Day of Women and Girls in Science Read More
Employee Stories: The Women in STEM Committee at the WuXi Biologics Ireland Site
PEGS Boston
May 2-6 | Boston MA
BIO International Convention
June 13-16 | San Diego, CA
For more information visit our website at www.wuxibiologics.com
or email us at [email protected]. 
For worldwide career opportunities visit us today.